International Cooperative Phase III Trial of the HIT-HGG Study Group (HIT-HGG-2013)

Clinical trial NCT03243461 · UNKNOWN

Trial details

NCT number: NCT03243461
Sponsor: University of Göttingen
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Glioblastoma WHO Grade IV Diffuse Midline Glioma Histone 3 K27M WHO Grade IV Anaplastic Astrocytoma WHO Grade III Diffuse Intrinsic Pontine Glioma Gliomatosis Cerebri

Start date: 2018-07-17
Primary completion: 2023-12-31
Enrollment: 167

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.